Farther Finance Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 151 shares of AGIO stock, worth $6,027. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151
Previous 12
1158.33%
Holding current value
$6,027
Previous $329,000
1426.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$228 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$224 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$194 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$140 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$97.8 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.19B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...